Gara Jalqabaatti › Diabetes Type 1
Qorannoo klinikaalii Diabetes Type 1 Ameerikaa Keessatti hirmaatuu
Qorannoo 139 Diabetes Type 1 f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Aurora, COQorannoo 23
- Boston, MAQorannoo 21
- Seattle, WAQorannoo 18
- Chicago, ILQorannoo 16
- New York City, NYQorannoo 15
- New Haven, CTQorannoo 15
- Indianapolis, INQorannoo 14
- San Francisco, CAQorannoo 14
- Miami, FLQorannoo 13
- Gainesville, FLQorannoo 12
- Atlanta, GAQorannoo 11
- Philadelphia, PAQorannoo 11
- Minneapolis, MNQorannoo 10
- Durham, NCQorannoo 10
- Houston, TXQorannoo 9
- Charlottesville, VAQorannoo 9
- Nashville, TNQorannoo 8
- Cleveland, OHQorannoo 7
- Dallas, TXQorannoo 7
- Pittsburgh, PAQorannoo 7
- Orlando, FLQorannoo 7
- Buffalo, NYQorannoo 6
- San Diego, CAQorannoo 6
- Baltimore, MDQorannoo 6
- Kansas City, MOQorannoo 6
- Los Angeles, CAQorannoo 6
- Columbus, OHQorannoo 6
- Jacksonville, FLQorannoo 5
- Tampa, FLQorannoo 5
- Detroit, MIQorannoo 5
- Memphis, TNQorannoo 4
- Baldwin Park, CAQorannoo 4
- Mountain View, CAQorannoo 4
- Rochester, MNQorannoo 4
- Louisville, KYQorannoo 4
- Ann Arbor, MIQorannoo 3
- St. Louis, MOQorannoo 3
- Austin, TXQorannoo 3
- Concord, CAQorannoo 3
- The Bronx, NYQorannoo 3
Naannoon
- ArizonaQorannoo 3
- CaliforniaQorannoo 37
- ColoradoQorannoo 24
- ConnecticutQorannoo 16
- FloridaQorannoo 30
- GeorgiaQorannoo 13
- IllinoisQorannoo 16
- IndianaQorannoo 14
- KentuckyQorannoo 6
- MarylandQorannoo 6
- MassachusettsQorannoo 21
- MichiganQorannoo 8
- MinnesotaQorannoo 13
- MissouriQorannoo 9
- New YorkQorannoo 23
- North CarolinaQorannoo 12
- OhioQorannoo 13
- OregonQorannoo 3
- PennsylvaniaQorannoo 13
- TennesseeQorannoo 11
- TexasQorannoo 16
- UtahQorannoo 5
- VirginiaQorannoo 10
- WashingtonQorannoo 20
- WisconsinQorannoo 3
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
Advancing Precision Nutrition: Wearable Technology for Noninvasive Insulin Monitoring
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 18 hanga 90 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07254364Integrating New Skills Into Diabetes Education With CGM
Namoota walitti qabaa jira
Umuriin 65 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07463209Clinical Application of Stem Cell Educator Therapy in Type 1 Diabetes
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 10 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT04011020Finding Immune Nascent Type 1 Diabetes
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 1 hanga 99 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07663136A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Orally Administered TIX100 in Healthy Subjects
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07675590Starting Technology in At Risk Type 1 Diabetes Study
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06453928A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07803744App-Based Certified Diabetes Education Therapy (AB-CDE)
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07282639ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2
Namoota walitti qabaa jira
Umuriin 8 hanga 21 · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT05463289A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 1 hanga 35 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07222137A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 1 hanga 35 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07222332Type 1 Diabetes Extension Study
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 8 hanga 35 · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT02734277METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 69 · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT07699380A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 1 hanga 25 · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT07088068CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 12 hanga 35 · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT06783309Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 4 hanga 34 · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT07216391Study Comparing Acceptance and Commitment Therapy to Supportive Diabetes Counseling and a Waitlist Control for Eating Disorders in Type 1 Diabetes
Namoota walitti qabaa jira
Umuriin 16 hanga 50 · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT05540704C-Carbs: A CGM-guided Approach to Teaching Carb Awareness
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT07807280The iLet Experience Study
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 6 fi ol · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT06891898Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 8 hanga 45 · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT07142252A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 9 hanga 20 · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT07061574A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 01-Ful-2026 · NCT04786262Remedy to Diabetes Distress (R2D2): A Scalable Screen to Treat Program for School-age Families
Namoota walitti qabaa jira
Umuriin 8 hanga 65 · Saalaa hunda · Haaromfame 01-Ful-2026 · NCT05268250HLA Demographics Study in Adults With Type 1 Diabetes
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 55 · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT06860516Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
Namoota walitti qabaa jira
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT07599982Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.